Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEGylated recombinant human growth hormone in children with idiopathic short stature
ChiCTR2500098245Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- Mar 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Tongji Hospital. Primary endpoint: Change in height standard deviation score after 52 weeks. Started Mar 2025; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on ChiCTR2500098245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098245.